Gregson NA - Search Results

1

Brain-derived neurotrophic factor in experimental autoimmune neuritis.

Felts PA, Smith KJ, Gregson NA, Hughes RA. Felts PA, et al. Among authors: gregson na. J Neuroimmunol. 2002 Mar;124(1-2):62-9. doi: 10.1016/s0165-5728(02)00017-6. J Neuroimmunol. 2002. PMID: 11958823

2

Axonal protection in experimental autoimmune neuritis by the sodium channel blocking agent flecainide.

Bechtold DA, Yue X, Evans RM, Davies M, Gregson NA, Smith KJ. Bechtold DA, et al. Among authors: gregson na. Brain. 2005 Jan;128(Pt 1):18-28. doi: 10.1093/brain/awh328. Epub 2004 Oct 27. Brain. 2005. PMID: 15509620

3

Reduced circulating CD4+CD25+ cell populations in Guillain-Barré syndrome.

Pritchard J, Makowska A, Gregson NA, Hayday AC, Hughes RA. Pritchard J, et al. Among authors: gregson na. J Neuroimmunol. 2007 Feb;183(1-2):232-8. doi: 10.1016/j.jneuroim.2006.12.002. Epub 2007 Jan 18. J Neuroimmunol. 2007. PMID: 17239444

4

Mesenchymal stem cells lack efficacy in the treatment of experimental autoimmune neuritis despite in vitro inhibition of T-cell proliferation.

Sajic M, Hunt DP, Lee W, Compston DA, Schweimer JV, Gregson NA, Chandran S, Smith KJ. Sajic M, et al. Among authors: gregson na. PLoS One. 2012;7(2):e30708. doi: 10.1371/journal.pone.0030708. Epub 2012 Feb 16. PLoS One. 2012. PMID: 22359549 Free PMC article.

5

Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy.

Meléndez-Vásquez C, Redford J, Choudhary PP, Gray IA, Maitland P, Gregson NA, Smith KJ, Hughes RA. Meléndez-Vásquez C, et al. Among authors: gregson na. J Neuroimmunol. 1997 Mar;73(1-2):124-34. doi: 10.1016/s0165-5728(96)00189-0. J Neuroimmunol. 1997. PMID: 9058768

6

Human immunoglobulin ameliorates rat experimental autoimmune neuritis.

Gabriel CM, Gregson NA, Redford EJ, Davies M, Smith KJ, Hughes RA. Gabriel CM, et al. Among authors: gregson na. Brain. 1997 Sep;120 ( Pt 9):1533-40. doi: 10.1093/brain/120.9.1533. Brain. 1997. PMID: 9313637

7

A combined inhibitor of matrix metalloproteinase activity and tumour necrosis factor-alpha processing attenuates experimental autoimmune neuritis.

Redford EJ, Smith KJ, Gregson NA, Davies M, Hughes P, Gearing AJ, Miller K, Hughes RA. Redford EJ, et al. Among authors: gregson na. Brain. 1997 Oct;120 ( Pt 10):1895-905. doi: 10.1093/brain/120.10.1895. Brain. 1997. PMID: 9365379

8

Pathogenesis of Guillain-Barré syndrome.

Hughes RA, Hadden RD, Gregson NA, Smith KJ. Hughes RA, et al. Among authors: gregson na. J Neuroimmunol. 1999 Dec;100(1-2):74-97. doi: 10.1016/s0165-5728(99)00195-2. J Neuroimmunol. 1999. PMID: 10695718 Review.

9

Anti-PMP22 antibodies in patients with inflammatory neuropathy.

Gabriel CM, Gregson NA, Hughes RA. Gabriel CM, et al. Among authors: gregson na. J Neuroimmunol. 2000 May 1;104(2):139-46. doi: 10.1016/s0165-5728(99)00269-6. J Neuroimmunol. 2000. PMID: 10713353

10

Guillain-Barré syndrome serum and anti-Campylobacter antibody do not exacerbate experimental autoimmune neuritis.

Hadden RD, Gregson NA, Gold R, Willison HJ, Hughes RA. Hadden RD, et al. Among authors: gregson na. J Neuroimmunol. 2001 Oct 1;119(2):306-16. doi: 10.1016/s0165-5728(01)00390-3. J Neuroimmunol. 2001. PMID: 11585634

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters